Multiple FDG-PET/CT scans can influence lung cancer treatment

February 20, 2015

By showing how four or more follow-up FDG-PET/CT scans for lung cancer can alter patient treatment plans, researchers at Johns Hopkins University are making the case for expanded Medicare reimbursement for these exams in a new article in the February edition of the Journal of Nuclear Medicine.

Currently, the U.S. Centers for Medicare and Medicaid Services (CMS) will pay for only three FDG-PET/CT scans when they are used to guide subsequent management of antitumor treatment after initial cancer therapy. Local Medicare administrative contractors must approve coverage for any additional FDG-PET/CT scans.

Read the full story.